AtriCure Financial Statements From 2010 to 2025

ATRC Stock  USD 39.93  0.50  1.27%   
AtriCure financial statements provide useful quarterly and yearly information to potential AtriCure investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on AtriCure financial statements helps investors assess AtriCure's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting AtriCure's valuation are summarized below:
Gross Profit
347.5 M
Profit Margin
(0.1)
Market Capitalization
B
Enterprise Value Revenue
4.0428
Revenue
465.3 M
We have found one hundred twenty available fundamental signals for AtriCure, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of AtriCure's prevailing performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. As of February 27, 2025, Market Cap is expected to decline to about 60.5 M. In addition to that, Enterprise Value is expected to decline to about 54.9 M

AtriCure Total Revenue

488.57 Million

Check AtriCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AtriCure's main balance sheet or income statement drivers, such as Interest Expense of 6.7 M, Total Revenue of 488.6 M or Gross Profit of 364.9 M, as well as many indicators such as Price To Sales Ratio of 2.94, Dividend Yield of 0.0 or PTB Ratio of 3.71. AtriCure financial statements analysis is a perfect complement when working with AtriCure Valuation or Volatility modules.
  
Check out the analysis of AtriCure Correlation against competitors.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

AtriCure Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets639.8 M609.3 M365.6 M
Slightly volatile
Total Stockholder Equity484 M461 M250.8 M
Slightly volatile
Other Assets0.860.91.6 M
Pretty Stable
Common Stock Shares Outstanding25.3 M47.1 M31 M
Slightly volatile
Liabilities And Stockholders Equity639.8 M609.3 M365.6 M
Slightly volatile
Other Stockholder Equity906.9 M863.7 M483.5 M
Slightly volatile
Total Liabilities83.9 M148.4 M110.3 M
Slightly volatile
Other Current Liabilities47.9 M45.6 M23.9 M
Slightly volatile
Total Current Liabilities77.1 M73.4 M40.5 M
Slightly volatile
Accounts Payable26.3 M25 M13.6 M
Slightly volatile
Cash128.9 M122.7 M42.6 M
Slightly volatile
Inventory79.1 M75.3 M30.6 M
Slightly volatile
Other Current Assets9.9 M9.4 MM
Slightly volatile
Common Stock29.3 K49 K33.1 K
Slightly volatile
Property Plant Equipment51.5 M49 M26.5 M
Slightly volatile
Property Plant And Equipment Net49.8 M47.4 M27 M
Slightly volatile
Non Current Assets Total358.6 M341.5 M221.9 M
Slightly volatile
Non Currrent Assets OtherM2.9 M966.8 K
Slightly volatile
Cash And Short Term Investments67.8 M122.7 M78 M
Slightly volatile
Net Receivables63.4 M60.3 M27.9 M
Slightly volatile
Common Stock Total Equity28.2 K54 K33.3 K
Slightly volatile
Non Current Liabilities Total61.1 M74.9 M75.6 M
Slightly volatile
Property Plant And Equipment Gross114.1 M108.7 M38.1 M
Slightly volatile
Total Current Assets281.2 M267.8 M144.3 M
Slightly volatile
Short and Long Term Debt Total80.4 M76.5 M43.5 M
Slightly volatile
Long Term Debt65 M61.9 M33.2 M
Slightly volatile
Good Will283.5 M270 M139 M
Slightly volatile
Short Term Debt2.3 M2.8 M2.4 M
Slightly volatile
Intangible Assets38.1 M56.5 M45.6 M
Slightly volatile
Other Liabilities1.3 M1.4 M33.3 M
Pretty Stable
Current Deferred Revenue978.9 K797.4 K1.1 M
Slightly volatile
Long Term Debt Total34.9 M65.4 M33.9 M
Slightly volatile
Capital Surpluse470.9 M905.5 M463.7 M
Slightly volatile
Non Current Liabilities Other1.1 M1.2 M36.7 M
Pretty Stable
Short and Long Term Debt3.2 M2.8 MM
Pretty Stable
Capital Lease Obligations10.3 M11.9 M12.9 M
Slightly volatile
Net Invested Capital463.5 M525.6 M321 M
Slightly volatile
Net Working Capital167.5 M194.4 M108.6 M
Slightly volatile
Capital Stock49.3 K49 K42.2 K
Slightly volatile

AtriCure Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue488.6 M465.3 M211.3 M
Slightly volatile
Gross Profit364.9 M347.5 M155.9 M
Slightly volatile
Other Operating Expenses530.6 M505.3 M237.4 M
Slightly volatile
Cost Of Revenue123.7 M117.8 M55.4 M
Slightly volatile
Total Operating Expenses406.9 M387.5 M182 M
Slightly volatile
Income Tax Expense798.3 KM451.6 K
Pretty Stable
Selling General Administrative305.9 M291.4 M130.4 M
Slightly volatile
Research Development101 M96.2 M40.6 M
Slightly volatile
Depreciation And Amortization19.7 M18.7 M8.7 M
Slightly volatile
Tax Provision1.1 MM247.2 K
Slightly volatile
Interest Income4.7 M4.4 M1.4 M
Slightly volatile
Reconciled Depreciation12.7 M18.7 M10.6 M
Slightly volatile
Non Recurring65.8 M74.1 M80.8 M
Slightly volatile

AtriCure Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures24.6 M23.5 M12.3 M
Slightly volatile
End Period Cash Flow128.9 M122.7 M42.6 M
Slightly volatile
Begin Period Cash Flow88.5 M84.3 M32.7 M
Slightly volatile
Depreciation19.7 M18.7 M8.7 M
Slightly volatile
Stock Based Compensation42.4 M40.4 M18 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.943.093782.415
Slightly volatile
PTB Ratio3.713.12285.6555
Slightly volatile
Days Sales Outstanding56.9647.331651.2435
Slightly volatile
Book Value Per Share10.289.7866.4266
Slightly volatile
Average PayablesM3.7 M3.7 M
Very volatile
Stock Based Compensation To Revenue0.05730.08050.0729
Slightly volatile
Capex To Depreciation2.682.551.6021
Pretty Stable
PB Ratio3.713.12285.6555
Slightly volatile
EV To Sales2.842.994482.423
Slightly volatile
Inventory Turnover2.621.56352.3422
Slightly volatile
Days Of Inventory On Hand133233170
Slightly volatile
Payables Turnover4.414.70534.1797
Very volatile
Sales General And Administrative To Revenue0.780.740.6804
Very volatile
Average Inventory3.8 M5.5 M5.7 M
Pretty Stable
Research And Ddevelopement To Revenue0.220.20670.192
Very volatile
Capex To Revenue0.09940.09470.0645
Pretty Stable
Cash Per Share1.742.60532.2458
Slightly volatile
Days Payables Outstanding10977.572193.6853
Very volatile
Intangibles To Total Assets0.260.4780.3912
Slightly volatile
Current Ratio3.813.64773.3368
Slightly volatile
Receivables Turnover5.747.71157.2035
Slightly volatile
Graham Number14.1714.454510.6495
Slightly volatile
Shareholders Equity Per Share10.289.7866.4266
Slightly volatile
Debt To Equity0.150.1660.204
Pretty Stable
Capex Per Share0.860.820.4186
Slightly volatile
Average Receivables4.5 M7.5 M7.7 M
Pretty Stable
Revenue Per Share10.379.87815.6629
Slightly volatile
Interest Debt Per Share1.851.76071.2052
Slightly volatile
Debt To Assets0.0880.12560.1162
Very volatile
Operating Cycle175281220
Slightly volatile
Price Book Value Ratio3.713.12285.6555
Slightly volatile
Days Of Payables Outstanding10977.572193.6853
Very volatile
Company Equity Multiplier1.11.32181.5726
Slightly volatile
Long Term Debt To Capitalization0.0960.13790.1276
Pretty Stable
Total Debt To Capitalization0.120.14240.1572
Pretty Stable
Debt Equity Ratio0.150.1660.204
Pretty Stable
Quick Ratio3.162.62162.7029
Slightly volatile
Net Income Per E B T1.111.02341.0123
Slightly volatile
Cash Ratio1.281.67140.945
Pretty Stable
Cash Conversion Cycle213203135
Slightly volatile
Days Of Inventory Outstanding133233170
Slightly volatile
Days Of Sales Outstanding56.9647.331651.2435
Slightly volatile
Price To Book Ratio3.713.12285.6555
Slightly volatile
Fixed Asset Turnover12.299.819510.0997
Slightly volatile
Debt Ratio0.0880.12560.1162
Very volatile
Price Sales Ratio2.943.093782.415
Slightly volatile
Asset Turnover0.940.76360.738
Slightly volatile
Gross Profit Margin0.580.74690.7121
Pretty Stable
Price Fair Value3.713.12285.6555
Slightly volatile

AtriCure Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap60.5 M79.2 M81.8 M
Pretty Stable
Enterprise Value54.9 M73.6 M76 M
Pretty Stable

AtriCure Fundamental Market Drivers

Cash And Short Term Investments122.7 M

AtriCure Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About AtriCure Financial Statements

AtriCure stakeholders use historical fundamental indicators, such as AtriCure's revenue or net income, to determine how well the company is positioned to perform in the future. Although AtriCure investors may analyze each financial statement separately, they are all interrelated. For example, changes in AtriCure's assets and liabilities are reflected in the revenues and expenses on AtriCure's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AtriCure. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue797.4 K978.9 K
Total Revenue465.3 M488.6 M
Cost Of Revenue117.8 M123.7 M
Stock Based Compensation To Revenue 0.08  0.06 
Sales General And Administrative To Revenue 0.74  0.78 
Research And Ddevelopement To Revenue 0.21  0.22 
Capex To Revenue 0.09  0.10 
Revenue Per Share 9.88  10.37 
Ebit Per Revenue(0.09)(0.09)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:
Check out the analysis of AtriCure Correlation against competitors.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.95)
Revenue Per Share
9.908
Quarterly Revenue Growth
0.166
Return On Assets
(0.04)
Return On Equity
(0.1)
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.